CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +8,542 | $12.50 | $107K | 22,761 |
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +1,458 | $34.39 | $50K | 24,219 |
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −500 | $101.98 | $51K | 23,719 |
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −801 | $103.16 | $83K | 22,918 |
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −799 | $104.25 | $83K | 22,119 |
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −6,842 | $105.28 | $720K | 15,277 |
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −958 | $106.18 | $102K | 14,319 |
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −100 | $107.00 | $11K | 14,219 |
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −8,542 | 67,834 | ||
| 2026-11-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,458 | 55,417 | ||
| 2026-10-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +8,541 | $12.50 | $107K | 22,760 |
| 2026-10-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +1,458 | $34.39 | $50K | 24,218 |
| 2026-10-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −5,741 | $80.03 | $459K | 18,477 |
| 2026-10-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −2,100 | $80.76 | $170K | 16,377 |
| 2026-10-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −1,958 | $81.86 | $160K | 14,419 |
| 2026-10-12 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −200 | $82.84 | $17K | 14,219 |
| 2026-10-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −8,541 | 76,376 | ||
| 2026-10-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,458 | 56,875 | ||
| 2026-09-21 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −533 | $95.75 | $51K | 14,219 |
| 2026-09-15 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −560 | $95.71 | $54K | 14,752 |
Page 1 of 4 · 67 trades